FORMULATIONS OF ANTI-VIRAL COMPOUNDS

A pharmaceutical composition comprising a compound of Formula (I)or a pharmaceutically acceptable salt thereof;wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioate,...

Full description

Saved in:
Bibliographic Details
Main Authors BANDYOPADHYAY, Susen, SINGH, Gurpartap, VALENTINO, Leann, J, RODRIGUEZ, Meghan, M, BANDYOPADHYAY, Rebanta
Format Patent
LanguageEnglish
French
German
Published 05.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A pharmaceutical composition comprising a compound of Formula (I)or a pharmaceutically acceptable salt thereof;wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioate, or an N-linked phosphoramidite, andat least one pharmaceutically acceptable excipient selected from a cysteine compound, an amino acid, an N-acetyl amino acid, an acid or a salt thereof, or any combination thereof.The pharmaceutical composition can be used for the effective treatment of viral infections in humans and other animal species caused by viruses, in particular, RNA viruses and can be administered orally or parenterally.
Bibliography:Application Number: EP20210733356